How Noom Med, Calibrate, and Found Prescribe GLP-1 (2026)
Noom Med and Found both pair GLP-1 medication with coaching for weight loss. We compare pricing, coaching models, clinical evidence, and medication options side-by-side to help you choose, and show where a medication-focused provider like Trimi fits in.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Our team updates competitor reviews when pricing, medication access, or program structures change so patients can compare options with current data.
Quick links: Semaglutide treatment, tirzepatide treatment, and cheapest GLP-1 injections guide.
More on GLP-1 Provider Comparisons
Noom vs Found for Weight Loss: What You Need to Know
If you are comparing noom vs found weight loss programs, you are choosing between two telehealth platforms that combine GLP-1 medication with coaching support. Noom Med pairs semaglutide prescriptions with the Noom app's behavioral psychology coaching. Found pairs GLP-1 medications with its own weight-loss-focused coaching and clinical team. Both charge significantly more than medication-only providers because they bundle coaching into the subscription price.
Noom Med vs Found, defined: Noom Med is the prescription arm of Noom, the popular calorie-tracking and behavioral change app, now expanded to include GLP-1 medications such as semaglutide and tirzepatide. Found is a standalone telehealth weight loss company built specifically around prescription weight loss medications, offering compounded semaglutide and tirzepatide alongside coaching and behavioral support. Both are legitimate telehealth providers with licensed medical teams, but they differ meaningfully in coaching style, pricing structure, and overall cost.
The central question for most patients is whether the coaching component justifies the premium. Clinical trial data consistently shows that GLP-1 medication is the primary driver of weight loss outcomes. The STEP 1 trial demonstrated 14.9% body weight loss with semaglutide at 68 weeks, with both the treatment and placebo groups receiving lifestyle counseling (Wilding et al., NEJM, 2021). This means the coaching both groups received contributed roughly the same amount, while the medication accounted for the difference. Patients who want the medication without paying a premium for coaching may prefer a provider like Trimi, which offers semaglutide at $99 per month and tirzepatide at $125 per month on its annual plan (a 12-month commitment), with clinical oversight included.
Noom Med vs Found vs Trimi: Side-by-Side Comparison
| Feature | Noom Med | Found | Trimi |
|---|---|---|---|
| Semaglutide monthly cost | $249/mo after a $129 first month (billed every 12 weeks) | $169–$289 per 28 days (cash); from $99 with insurance + visit copay | From $99/mo (annual plan) |
| Tirzepatide monthly cost | $299/mo after a $149 first month (billed every 12 weeks) | $239–$359 per 28 days (cash) | From $125/mo (annual plan) |
| Additional app/coaching fee | None (app and coaching included) | Included in price | None |
| Lowest rate requires | No longer plan offered; recurring 12-week billing | 12-month plan paid up front | Annual plan (12-month commitment) |
| Coaching model | App-based CBT + psychology | Weight-loss-focused coaching | Clinical guidance |
| Medication included in price | Yes (med subscription) | Yes | Yes |
| Flat dose-independent pricing | Yes (priced per program) | Yes (same price every dose) | Yes |
| Provider visits included | Yes | Yes | Yes |
| Plan terms | Recurring 12-week billing; cancel before the next cycle | Month to month, or 3, 6, or 12-month plans | Annual plan is a 12-month commitment; monthly plan available |
| Refunds and early exit | No refunds once a prescription is written | 12-month plans are paid up front | Annual plan backed by a 6-month money-back policy |
| 12-month total (semaglutide) | About $3,117 (first year at $249) | $2,028 or more (12-month cash plan) | $1,188 (annual plan) |
| Best for | Patients who value Noom's behavioral psychology app alongside medication | Patients wanting weight-loss coaching at a moderate price | Patients wanting the best value for clinical GLP-1 care |
Prices were re-checked on 29 September 2026 on each provider's own site. Noom and Found both bill in 4-week (28-day) periods, so a year on a recurring plan is 13 billing periods. Noom's pricing page lists GLP-1Rx at $249 a month, while a footnote on its GLP-1Rx page lists $279 a month. Verify current pricing directly with each provider before enrolling.
Pricing Breakdown: What You Actually Pay
Cost is the single most important differentiator for the majority of patients considering GLP-1 treatment, and the pricing structures between Noom Med and Found differ in ways that are not immediately obvious. Understanding the true monthly cost requires looking beyond the headline medication price.
Noom Med Pricing
Noom's compounded semaglutide program, GLP-1Rx, costs $129 for the first 4-week supply, then $249 a month, billed every 12 weeks. That price covers the medication, clinician visits, coaching, and full access to the Noom app, so there is no separate app fee. One footnote on Noom's GLP-1Rx page lists $279 a month instead, so confirm the rate at checkout. Noom also sells a lower-dose Microdose GLP-1Rx program ($79 to start, then $179 a month) and a compounded tirzepatide program, GLP-1Rx Plus ($149 to start, then $299 a month). Over the first year, thirteen 4-week supplies of GLP-1Rx come to about $3,117 at the $249 rate. For a detailed look at potential Noom Med side effects, see our dedicated guide.
Found Pricing
On cash pay, Found charges one plan price per 28-day cycle: $169 to $289 for compounded semaglutide and $239 to $359 for compounded tirzepatide, depending on plan length. Its insurance track costs less per cycle, $99 to $199 for semaglutide, plus a copay for each required video visit, which Found says is typically around $30. Found's pricing includes coaching and clinical services in the subscription, so there is no separate app fee. Found charges the same price at every dose; its price is set by plan length, with month to month costing the most per 28-day cycle. On its 12-month cash plan, a year of semaglutide costs $2,028 or more; month to month, it comes to $3,647 over 13 cycles. Patients considering Found should review our guide on Found weight loss side effects before enrolling. Our full Found weight loss review covers the program structure, coaching model, and verdict in more depth.
Trimi Pricing
Trimi charges $99 per month for semaglutide and $125 per month for tirzepatide on its annual plan (a 12-month commitment), or $175 and $235 month to month. This price is flat and dose-independent, meaning you pay the same amount whether you are on a starting dose or a maintenance dose. There are no additional fees for app access, coaching, consultations, or shipping. The twelve-month total for semaglutide on Trimi's annual plan is $1,188. That is about $1,929 less than a first year of Noom GLP-1Rx at $249 a month and at least $840 less than Found's 12-month cash plan. For a broader comparison of affordable options, see our cheapest GLP-1 injections 2026 guide.
Coaching Approaches: Behavioral Psychology vs Weight Loss Focus
The coaching component is what Noom Med and Found use to justify their higher prices. Both platforms include coaching, but the methodology and delivery differ meaningfully. Understanding these differences helps you decide whether the coaching premium is worth paying.
Noom Med Coaching
Rooted in cognitive behavioral therapy (CBT) principles
App-based daily lessons on food psychology and habit formation
Color-coded food classification system (green, yellow, red)
Daily calorie logging and meal tracking within the Noom app
Group coaching with other Noom users
Goal-setting and progress tracking tools
Focus on changing your relationship with food over time
Found Coaching
Weight-loss-specific coaching and behavioral support
In-app messaging with assigned health coaches
Medication management integrated into coaching workflow
Behavioral science-informed content and tools
Community features and peer support within the app
Side effect management guidance alongside coaching
Focus on practical strategies for weight loss with medication
Noom Med's coaching is better suited for patients who want a structured behavioral psychology program that addresses the underlying habits and thought patterns behind overeating. The CBT-based approach is evidence-informed and provides a comprehensive framework for long-term behavioral change. Found's coaching is more practically oriented toward the weight loss journey itself, integrating medication management with lifestyle adjustments and side effect support.
The coaching question most patients should ask
Both Noom Med and Found charge a significant premium for coaching. The honest question is whether you will consistently engage with the coaching tools over 12 or more months. Many patients report high engagement in the first few weeks that tapers significantly by month three. If you suspect you will primarily rely on the medication rather than the coaching, a medication-focused provider like Trimi delivers the same clinical outcome at substantially lower cost.
Clinical Evidence: What Actually Drives Weight Loss
Neither Noom Med nor Found has published peer-reviewed clinical trials demonstrating that their specific coaching programs produce outcomes superior to medication with standard clinical oversight. The clinical evidence for GLP-1 weight loss comes from large-scale randomized controlled trials of the medications themselves, not from any individual telehealth platform's coaching methodology.
Semaglutide: STEP 1 Trial Results
The landmark STEP 1 trial enrolled 1,961 adults and demonstrated that semaglutide 2.4 mg produced an average of 14.9% body weight loss over 68 weeks, compared to 2.4% with placebo. Critically, both groups received lifestyle counseling, meaning the medication, not the counseling, drove the 12.5 percentage point difference (Wilding et al., New England Journal of Medicine, 2021). This is the foundational evidence supporting every semaglutide-based program, including Noom Med, Found, and Trimi.
Tirzepatide: SURMOUNT-1 Trial Results
The SURMOUNT-1 trial enrolled 2,539 adults and showed that tirzepatide produced 15% to 20.9% body weight loss over 72 weeks at various doses, compared to 3.1% with placebo. Both groups received lifestyle counseling. The dual GIP/GLP-1 mechanism of tirzepatide produced even greater weight loss than semaglutide alone (Jastreboff et al., New England Journal of Medicine, 2022). Found and Trimi both offer tirzepatide; Noom Med's tirzepatide availability is more limited.
Intensive Coaching vs Standard Counseling
A 2024 study by Wadden et al. in the New England Journal of Medicine compared semaglutide plus intensive behavioral therapy against semaglutide with standard counseling. Both groups lost significant weight, and the intensive therapy group did not demonstrate a clinically meaningful advantage over the standard counseling group. This suggests that intensive coaching programs, the kind charged as premiums by Noom Med and Found, may not produce materially better outcomes than basic clinical guidance alongside GLP-1 medication.
SELECT Cardiovascular Trial
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide in patients with obesity and established cardiovascular disease (Lincoff et al., New England Journal of Medicine, 2023). This benefit is attributable to the medication itself, independent of any coaching methodology, further reinforcing that the pharmacological intervention is the primary therapeutic driver.
The clinical evidence is consistent: GLP-1 medications produce substantial, clinically meaningful weight loss. Coaching and behavioral support are beneficial for overall health and habit formation, but they are not the primary mechanism of weight loss in GLP-1 treatment. This distinction matters because Noom Med and Found charge a premium specifically for their coaching components. Patients should decide whether that premium aligns with their individual needs and budget, knowing that the medication itself accounts for the vast majority of expected weight loss.
Medication Options and Access
All three providers prescribe semaglutide for weight loss. All three also offer compounded tirzepatide; at Noom, it is sold as the GLP-1Rx Plus program. The active pharmaceutical ingredient is identical regardless of which provider prescribes it. Semaglutide works through the same GLP-1 receptor agonist mechanism whether it comes through Noom Med, Found, or Trimi, and tirzepatide works through the same dual GIP/GLP-1 mechanism regardless of provider.
Noom Med medications
Compounded semaglutide (GLP-1Rx, $249/mo after a $129 first month), compounded tirzepatide (GLP-1Rx Plus, $299/mo after a $149 first month), and a separate membership for brand-name GLP-1s, with the medication billed separately.
Found medications
Compounded semaglutide ($169–$289 per 28 days on cash pay) and tirzepatide ($239–$359 per 28 days), medication included in the plan price. Brand-name GLP-1s are billed separately.
Trimi medications
Semaglutide ($99/mo) and tirzepatide ($125/mo) on the annual plan. Compounded formulations from state-licensed 503A pharmacies. Flat pricing at all doses.
Who Should Choose Noom Med
Noom Med is the right fit if you specifically want Noom's behavioral psychology approach alongside your GLP-1 medication. Patients who have had success with the Noom app in the past and want to combine that methodology with prescription medication may find value in Noom Med's integrated experience. The CBT-based framework is well-designed for patients who struggle with emotional eating or food psychology and want structured daily guidance.
Noom Med is not the right choice if cost is a significant factor. At $249 a month for compounded semaglutide after the first month, with no discounted longer plan, it costs more over a year than Found's 12-month cash plan or Trimi's annual plan. Billing every 12 weeks also means paying for three months at a time. Patients who are primarily interested in the medication and do not plan to engage deeply with daily app lessons may be paying a substantial premium for features they will not use. If you are currently on Noom Med and looking for alternatives, our guide to canceling Noom Med covers the transition process step by step.
Who Should Choose Found
Found is the right fit if you want coaching support tailored specifically to weight loss with GLP-1 medication at a moderate price. Found's platform integrates medication management with coaching in a way that feels purpose-built for the GLP-1 weight loss experience. Found also offers an insurance track, which Noom's compounded programs do not.
Found is not the right choice if cost is your priority. Its price does not rise with dose, but the gap between its month-to-month and 12-month rates is significant. Some patients report difficulty with Found's cancellation process. If you are currently on Found and considering a switch, see our guide to canceling Found for detailed steps.
Who Should Choose Trimi
Trimi is the right fit if you want effective GLP-1 treatment at the lowest sustainable price without paying for coaching services you may not fully use. Flat pricing at every dose, no membership fee, no hidden fees, and responsive clinical support make Trimi the most financially straightforward option. Its lowest rates come with the annual plan, a 12-month commitment backed by a 6-month money-back policy. Access to both semaglutide and tirzepatide at dose-independent pricing means your cost never increases as your treatment progresses.
Trimi is not the right choice if you specifically want intensive app-based coaching (Noom Med) or structured weight-loss behavioral support (Found). Trimi's model focuses on clinical medication management rather than comprehensive behavioral programming. The trade-off is clear: patients who choose Trimi's annual plan save at least $840 a year versus Found's 12-month cash plan and about $1,929 versus Noom GLP-1Rx, but forgo the coaching platforms that Noom Med and Found provide. For patients who are self-motivated or prefer to supplement their GLP-1 treatment with their own exercise and nutrition strategies, this trade-off strongly favors Trimi.
The Bottom Line
Medication drives the clinical outcome
GLP-1 medication is the primary cause of weight loss in all three programs. The STEP 1 and SURMOUNT-1 trials demonstrate 14.9% to 20.9% weight loss from medication, with coaching contributing a marginal additional benefit at best. When you pay more at Noom Med or Found, you are primarily paying for coaching, not for a better medical outcome.
Noom Med costs the most, Found sits in the middle, Trimi costs the least
For semaglutide over twelve months: Noom GLP-1Rx totals about $3,117 at $249 a month, Found totals $2,028 or more on its 12-month cash plan, and Trimi totals $1,188 on its annual plan. Savings of $840 to about $1,929 a year by choosing Trimi are substantial, especially for a treatment that often continues for years.
Start with the medication, add coaching if you need it
Rather than starting with an expensive coaching-plus-medication program and downgrading later, consider starting with a cost-effective medication provider like Trimi. If you find you need additional behavioral support after beginning treatment, standalone coaching apps and nutritional counseling are available independently and often at lower cost than the premium charged by Noom Med or Found.
Frequently Asked Questions
Is Noom Med the same as regular Noom?
No. Regular Noom is a behavioral weight loss app that uses cognitive behavioral therapy techniques without medication. Noom Med is a separate clinical program that pairs GLP-1 medications like semaglutide with Noom's app-based coaching platform. Noom Med requires a medical evaluation and prescription, while the original Noom app is available to anyone. Noom's GLP-1 program prices cover the medication, clinician visits, coaching, and full access to the Noom app, so there is no separate app fee on its medication plans.
Does Found prescribe tirzepatide?
Yes. Found offers both semaglutide and tirzepatide as part of its GLP-1 weight loss program. Tirzepatide through Found costs $239 to $359 per 28-day cycle on cash pay, depending on plan length, with the medication included and the same price at every dose; Found's insurance track costs less per cycle plus visit copays. For comparison, Trimi offers tirzepatide at $125 per month on its annual plan (a 12-month commitment), also at the same price at every dose.
Which is cheaper, Noom Med or Found?
It depends on the plan length. Noom's GLP-1Rx program charges $129 for the first 4-week supply of compounded semaglutide, then $249 a month billed every 12 weeks, with the app and coaching included. On cash pay, Found charges $169 to $289 per 28-day cycle: its 3-month plan matches Noom at $249, its 6 and 12-month plans cost less ($219 and $169), and its month-to-month plan costs more ($289 after the first cycle). Found's insurance track starts at $99 per cycle plus visit copays. Both cost more than Trimi, which charges $99 per month for semaglutide on its annual plan (a 12-month commitment) or $175 month to month, with clinical services included.
Do I need coaching to lose weight on GLP-1 medication?
Clinical evidence suggests that GLP-1 medication is the primary driver of weight loss. The STEP 1 trial demonstrated 14.9 percent body weight loss with semaglutide compared to 2.4 percent with placebo, and coaching was provided to both groups (Wilding et al., NEJM, 2021). While behavioral coaching can support healthy habit formation, the medication produces the majority of the clinical effect. Many patients achieve excellent results with medication and standard clinical oversight alone, without premium coaching programs.
Can I switch from Noom Med or Found to a cheaper provider?
Yes. Switching from Noom Med or Found to another GLP-1 provider is straightforward. Your medication type and current dose transfer without interruption. The main consideration is timing the switch to avoid a gap in your medication supply. Review any contract terms or cancellation policies before switching. Detailed guides are available for canceling Noom Med and canceling Found.
Are Noom Med and Found legitimate medical providers?
Yes. Both Noom Med and Found employ licensed medical providers who evaluate patients, write prescriptions, and provide ongoing clinical oversight. Both partner with licensed pharmacies to dispense medication. They are legitimate telehealth platforms operating within standard medical and regulatory frameworks. The difference between them and other providers is in their supplementary services and pricing, not in the legitimacy of their medical care.
What happens if I stop paying for coaching but want to keep my medication?
If you stop your Noom Med or Found subscription, you will lose access to both the coaching platform and your medication prescription. These programs bundle coaching and medication together, so you cannot keep one without the other. To continue GLP-1 treatment without coaching, you would need to transfer your care to a medication-focused provider like Trimi, which charges $99 per month for semaglutide on its annual plan (a 12-month commitment), with clinical oversight included.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232.
- Wadden TA, et al. Intensive behavioral therapy and semaglutide for obesity. N Engl J Med. 2024.
- Noom Health, Inc. Noom Med official program and pricing information. 2026.
- Found Health, Inc. Found weight loss official program and pricing information. 2026.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Individual results vary. Trimi is a competing provider; this comparison is presented fairly but readers should verify current pricing and program details directly with each provider. Pricing information was re-checked against each provider's own site on 29 September 2026 and is subject to change.